Login / Signup

Anti-CD20 rechallenge with ofatumumab in relapsed/refractory splenic marginal zone lymphoma: the MORE trial.

Lydia ScarfòSilvia FerrariAnna Maria FrustaciMonica TaniAlessia BariEloise ScaranoMaria ColiaPamela RanghettiPiera AngelilloPaola RonchiMaurilio PonzoniAndrés José Maria FerreriPaolo Ghia
Published in: Blood advances (2022)
Keyphrases
  • diffuse large b cell lymphoma
  • acute lymphoblastic leukemia
  • phase iii
  • study protocol
  • acute myeloid leukemia
  • multiple myeloma
  • phase ii
  • hodgkin lymphoma
  • clinical trial
  • nk cells
  • open label
  • double blind